Recombinant anti-cd40 antibody and uses thereof
CA 2376485 C · Owner: Fell, Henry P. Jr. · Inventors: Fell, Henry P. Jr.; Wahl, Alan F.; Francisco, Joseph A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to methods and compositions for the prevention and treatment of cancer, inflammatory diseases and disorders or deficiencies of the immune system. The methods of the invention comprise administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 8, 2000 and granted September 20, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 8, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 8, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.